This bill (HR 4635) designates the U.S. Postal Service facility at 890 East 152nd Street in Cleveland, Ohio, as the "Technical Sergeant Alma Gladys Minter Post Office Building." It updates all official references to the location to use this new name, with no policy changes or direct impact on residents or services beyond the ceremonial renaming.
This resolution designates the week of August 2 through August 8, 2026, as "National Farmers Market Week" to honor the importance of local food markets. It serves as a symbolic gesture to recognize how these markets support farmers' livelihoods, strengthen local economies, and connect urban and rural communities. The bill does not create new laws or funding but instead formally acknowledges the role farmers markets play in promoting sustainable farming and public health.
This Senate resolution designates July 2026 as National Anti-Counterfeiting and Consumer Education and Awareness Month to highlight the economic and safety importance of trademarks. The bill aims to educate the public about the risks of counterfeit goods, such as unsafe medical products and electronics, and encourages awareness campaigns to reduce demand for these illegal items. By promoting education on how to identify genuine products, the resolution seeks to help consumers avoid harmful fakes while supporting brand owners and law enforcement efforts.
HR 4541, the EARLY Act Reauthorization of 2025, extends the funding period for the Young Women’s Breast Health Education and Awareness program. It amends the Public Health Service Act to update the program’s expiration date from 2026 to 2031. The bill directly affects young women aged 15-25 by ensuring continued access to breast health education and awareness resources. The key provision is a simple extension of the existing program’s authorization period, without altering its scope or requirements. This is a procedural reauthorization to maintain current services through 2031.
This bill reauthorizes and expands the Accelerating Access to Critical Therapies for ALS Act through 2031, extending funding for research into treatments for amyotrophic lateral sclerosis. It requires drug manufacturers to share interim clinical trial data with the FDA to better assess the progress of investigational drugs and clarifies that phase 3 clinical trial definitions include combined phase 2/3 trials and planned trials not yet enrolling participants. The legislation also mandates the FDA to publish an updated five-year action plan for ALS and other rare neurodegenerative diseases, including resource needs and coordination strategies with broader disease communities. Additionally, the bill requires the Government Accountability Office to submit a report on the program's implementation four years after enactment.
The Main Street Capital Access Act reduces regulatory burdens for smaller banks, particularly those with less than $10 billion in assets. Key provisions include a 3-year phase-in period for new banks to meet capital requirements, lower leverage ratio requirements for rural banks (7.5% for the first 2 years), and a 30-day review process for business plan deviations. The bill also establishes an Office of Independent Examination Review, sets specific timelines for examinations (270 days) and reports (90 days), and creates a "least cost exception" for bank resolutions to prevent excessive concentration of the banking system. These changes aim to promote new bank formation, improve regulatory efficiency, and support community banking while maintaining financial stability.
This resolution provides for the consideration of the bill (H.R. 8800) to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes; providing for consideration of the bill (H.R. 8884) to amend title II of the Social Security Act to reauthorize demonstration authority for the disability insurance program; providing for consideration of the concurrent resolution (H. Con. Res. 113) establishing the congressional budget for the United States Government for fiscal year 2027 and setting forth the appropriate budgetary levels for fiscal years 2028 through 2036; providing for consideration of the bill (H.R. 7008) to amend chapter 131 of title 5 to require certain restrictions on stocks for Members of Congress and their spouses and dependents, and for other purposes; providing for consideration of the bill (H.R. 6955) to make improvements to the Federal banking laws, and for other purposes; providing for consideration of the bill (H.R. 9770) making continuing appropriations for fiscal year 2027, and for other purposes; and for other purposes.
The Next-Generation Geothermal Research and Development Act expands federal geothermal research to include advanced technologies like closed-loop and supercritical systems. It directs the Department of Energy to create a new research program, establish a center of excellence, and award grants for developing drilling equipment and materials needed for these systems. The bill also requires the creation of a public database for geothermal data and mandates periodic reports on water usage and the commercial potential of next-generation geothermal energy.
This bill reauthorizes federal programs focused on preventing and responding to tick-borne diseases through 2026-2030, extending existing efforts beyond their previous expiration. It updates the National Strategy for Vector-Borne Diseases to emphasize identifying, reporting, preventing, and responding to these illnesses. The bill modifies two sections of the Public Health Service Act to continue funding for health departments working on vector-borne disease control. It directly affects public health programs and state/local health departments managing tick-borne disease prevention and response.
The AADAPT Act reauthorizes and expands Project ECHO grants to improve Alzheimer’s and dementia care through technology-enabled training. It specifically funds grants for healthcare providers in rural, frontier, or medically underserved areas to enhance early diagnosis, quality care, and provider retention for dementia patients. The bill authorizes $1 million annually (2027-2032) for these dementia-focused training programs, requiring funds to supplement - not replace - existing resources. This directly supports primary care providers licensed to serve underserved communities, using collaborative online learning to address care gaps.
This bill establishes the INCLUDE Project at the National Institutes of Health (NIH) to advance research on Down syndrome and related health conditions. It requires NIH to fund high-risk studies on trisomy 21, support inclusive clinical trials for people with Down syndrome across all ages, and investigate co-occurring conditions like Alzheimer’s disease and autoimmunity. The law mandates NIH coordination across its institutes, consultation with patient advocates, and biennial reports to Congress detailing funded research and its real-world applications. The project directly affects individuals with Down syndrome, their families, and medical researchers, aiming to improve diagnosis, treatment, and quality of life through targeted scientific efforts.
HR 2715, the *Destruction of Hazardous Imports Act*, expands the authority to destroy imported goods that pose public health risks. It amends the Federal Food, Drug, and Cosmetic Act to allow the Secretary of Health and Human Services to order the destruction of any refused import (not just drugs or devices) if it presents a significant health concern. The bill also prohibits the unauthorized movement, sale, or export of such refused goods. These changes apply to importers of hazardous refused articles 180 days after enactment, with the FDA required to finalize implementing regulations within 90 days.
